# Breast Tomosynthesis: How I Read It

Now that digital breast tomosynthesis \(DBT\) has gained FDA approval, many breast-imaging providers find themselves excited about the new technology, but facing uncertainty about reimbursement, implementation, and interpretation workflow. There remain a number of questions related to the display of \(and approach to interpreting\) DBT that need to be addressed if DBT is to be incorporated optimally into routine practice. As they were for digital mammography \(DM\) in the recent past, the acquisition and dissemination of DBT technology will be marked by early and late adopters.

{% embed url="https://www.radiologybusiness.com/topics/business-intelligence/breast-tomosynthesis-how-i-read-it" %}



